FDA Warning Letter — Bloodworks
The FDA took a Warning Letter action against Bloodworks on Apr 16, 2013 (Seattle, WA). The action was issued by CBER and concerns biologics products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Bloodworks
- Date
- Apr 16, 2013
- Fiscal Year
- 2013
- Product Type
- Biologics
- Center
- CBER
- Location
- Seattle, WA (United States)